Chris Rallis - Jul 18, 2022 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A Rallis, Director
Stock symbol
FENC
Transactions as of
Jul 18, 2022
Transactions value $
-$24,339
Form type
4
Date filed
7/18/2022, 06:00 PM
Previous filing
Jun 16, 2022
Next filing
Oct 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Options Exercise $5K +11.1K +53.1% $0.45* 32K Jul 18, 2022 Direct F1
transaction FENC Common Shares Tax liability -$29.3K -4.38K -13.67% $6.70 27.7K Jul 18, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options granted on August 17, 2012, with a $0.45 USD strike price and an expiration of August 17, 2022.
F2 Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 11,111 shares from an August 17, 2012 grant.